Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, December 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent: 1 patent

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 26 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Exploring the time-dependent regulatory potential of microRNAs in breast cancer cells treated with proteasome inhibitors

Article in Clinical and Translational Oncology (December 2023)

Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo

Article in Biology Direct (April 2023)

The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment

Article in Recent Patents on Anti-Cancer Drug Discovery (January 2022)